Bradley McGregor

29PUBLICATIONS
271CO-AUTHORS
Molecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Aug 21, 2026
Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.

|Aug 05, 2026
Author Correction: Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.

|Jul 27, 2026
Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801).

|Jul 01, 2026
Casdatifan shows durable response linked to HIF-2α biology in kidney cancer.

|May 28, 2026
Unleashing Precision Oncology in the Development of Human Epidermal Growth Factor Receptor 2-Targeted Antibody Drug Conjugates for Urothelial Carcinoma.

|May 16, 2026
TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma.

Pageof 5

Frequent Collaborators

12 joint publications

Toni K Choueiri

9 joint publications

Rana R McKay

5 joint publications

Stephanie Berg

5 joint publications

Wanling Xie